Showing results (131-140 of 437) with videos related to
Sort By:
Pageof 44
Human Mutation|February 24, 2015
Oncotator: cancer variant annotation toolAlex H Ramos, Lee Lichtenstein, Manaswi Gupta, et al.ACS Chemical Biology|September 22, 2015
Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung CancerHideki Terai, Li Tan, Ellen M Beauchamp, et al.Nature Chemical Biology|November 3, 2025
Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugsAnanthan Sadagopan, Maximilian Carson, Eriks J Zamurs, et al.Cell|August 16, 2014
Cytokinesis failure triggers hippo tumor suppressor pathway activationNeil J Ganem, Hauke Cornils, Shang-Yi Chiu, et al.Blood|October 21, 2016
The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemiaHubo Li, Brenton G Mar, Huadi Zhang, et al.Biorxiv : the Preprint Server for Biology|August 14, 2023
XRN1 deletion induces PKR-dependent cell lethality in interferon-activated cancer cellsTao Zou, Meng Zhou, Akansha Gupta, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2006
Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohortsD Neil Hayes, Stefano Monti, Giovanni Parmigiani, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 2005
Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4cSatyajit K Karnik, Christina M Hughes, Xueying Gu, et al.ACS Chemical Biology|June 10, 2025
High-Throughput Screening Tool to Identify Small Molecule Inhibitors of TelomeraseElisa Aquilanti, Sulyman Barkho, Vincent Bozinov, et al.Molecular Cancer Therapeutics|June 2, 2026
Preclinical response of uveal melanomas to the velcrin compound, BAY 2666605Kristýna Kotýnková, Sawyer Andersen, Daniel Denney, et al.Pageof 44